Human Genome Epidemiology Literature Finder
Records 1 - 26 (of 26 Records) |
Query Trace: Lung Neoplasms and INS[original query] |
---|
EGFR and erbB2 mutation status in Japanese lung cancer patients. International journal of cancer. Journal international du cancer 2006 Jan 118 (1): 180-4. Sasaki Hidefumi, Shimizu Shigeki, Endo Katsuhiko, Takada Minoru, Kawahara Masaaki, Tanaka Hisaichi, Matsumura Akihide, Iuchi Keiji, Haneda Hiroshi, Suzuki Eriko, Kobayashi Yoshihiro, Yano Motoki, Fujii Yoshita |
Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis. Carcinogenesis 2010 Apr 31 (4): 643-7. Hu Zheng, Li Xiang, Qu Xincai, He Yungang, Ring Brian Z, Song Enmin, Su |
Functionally significant nicotine acetylcholine receptor subunit a5 promoter haplotypes are associated with susceptibility to lung cancer in Chinese. Cancer 2011 Oct 117 (20): 4714-23. Zheng Xia, Duan Wenyuan, Xu Jing, Nie Chenxia, Yang Zhangmin, Wang Hongyan, Wang Weimin, Lu Da |
C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC. Lung cancer (Amsterdam, Netherlands) 2013 Jul 81 (1): 123-9. Uzunoglu Faik Güntac, Yavari Neda, Bohn Benjamin Alexander, Nentwich Michael Fabian, Reeh Matthias, Pantel Klaus, Perez Daniel, Tsui Tung Yu, Bockhorn Maximilian, Mann Oliver, Izbicki Jakob Robert, Wikman Harriet, Vashist Yogesh Kum |
EGFR mutations in surgically resected fresh specimens from 697 consecutive Chinese patients with non-small cell lung cancer and their relationships with clinical features. International journal of molecular sciences 2013 14 (12): 24549-59. Lai Yuanyang, Zhang Zhipei, Li Jianzhong, Sun Dong, Zhou Yong'an, Jiang Tao, Han Yong, Huang Lijun, Zhu Yifang, Li Xiaofei, Yan Xiaolo |
Insertion/deletion polymorphisms in the promoter region of BRM contribute to risk of hepatocellular carcinoma in Chinese populations. PloS one 2013 8 (1): 1. Gao X, Huang M, Liu L, He Y, Yu Q, Zhao H, Zhou C, Zhang J, Zhu Z, Wan J, Jiang X, Gao Y |
Functional polymorphisms in NF?B1/I?Ba predict risks of chronic obstructive pulmonary disease and lung cancer in Chinese. Human genetics 2013 Apr 132 (4): 451-60. Huang Dongsheng, Yang Lei, Liu Yehua, Zhou Yumin, Guo Yuan, Pan Mingan, Wang Yunnan, Tan Yigang, Zhong Haibo, Hu Min, Lu Wenju, Ji Weidong, Wang Jian, Ran Pixin, Zhong Nanshan, Zhou Yifeng, Lu Jiach |
A literature-based systematic HuGE review and meta-analysis show that CASP gene family polymorphisms are associated with risk of lung cancer. Genetics and molecular research : GMR 2013 Jan 12 (AOP): AOP. Zhang ZY, Xuan Y, Jin XY, Tian X, Wu R |
RTN4 3'-UTR insertion/deletion polymorphism and susceptibility to non-small cell lung cancer in Chinese Han population. Asian Pacific journal of cancer prevention : APJCP 2014 15 (13): 5249-52. Lu De-Yi, Mao Xu-Hua, Zhou Ying-Hui, Yan Xiao-Long, Wang Wei-Ping, Zheng Ya-Biao, Xiao Juan-Juan, Zhang Ping, Wang Jian-Guo, Ashwani Neetika, Ding Wei-Liang, Jiang Hua, Shang Yan, Wang Ming-H |
Polymorphism in PHD1 gene and risk of non-small cell lung cancer in a Chinese population. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Sep 35 (9): 8921-5. Che Jianhua, Jiang Dong, Zheng Yabiao, Zhu Bin, Zhang Ping, Lu Deyi, Zhang Junjie, Xiao Juanjuan, Wang Jianguo, Gao Yuzhen, Yan Xiaolong, Wang Mingh |
Role of a genetic variant on the 15q25.1 lung cancer susceptibility locus in smoking-associated nasopharyngeal carcinoma. PloS one 2014 9 (10): e109036. Ji Xuemei, Zhang Weidong, Gui Jiang, Fan Xia, Zhang Weiwei, Li Yafang, An Guangyu, Zhu Dakai, Hu Qia |
Polymorphisms in NF-?B pathway genes & their association with risk of lung cancer in the Chinese population. Pakistan journal of medical sciences 0 31 (6): 1411-6. Zhang Jing-Wei, Chen Qiu-Sheng, Zhai Jian-Xia, Lv Peng-Ju, Sun Xiao-Y |
Thymidylate Synthase Polymorphisms and Risk of Lung Cancer among the Jordanian Population: a Case Control Study. Asian Pacific journal of cancer prevention : APJCP 2015 16 (18): 8287-92. Qasem Wiam Al, Yousef Al-Motassem, Yousef Mohammad, Manasreh Ih |
Genetic variation of lncRNA GAS5 contributes to the development of lung cancer. Oncotarget 2017 12 8 (53): 91025-91029. Li Weihao, Huang Kai, Wen Fengbiao, Cui Guanghui, Guo Haizhou, Zhao So |
Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients. Cancer chemotherapy and pharmacology 2017 Oct . Chen Kaiyan, Yu Xiaoqing, Wang Haiyang, Huang Zhiyu, Xu Yanjun, Gong Lei, Fan Y |
Correlations of an Insertion/Deletion Polymorphism (rs10680577) in the RERT-lncRNA with the Susceptibility, Clinicopathological Features, and Prognosis of Lung Cancer. Biochemical genetics 2018 Aug . Zhu Jing, Luo Jin-Zhu, Li Cheng-B |
Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients. Lung Cancer (Auckland, N.Z.) 2018 4 9 25-34. Syahruddin Elisna, Wulandari Laksmi, Sri Muktiati Nunuk, Rima Ana, Soeroso Noni, Ermayanti Sabrina, Levi Michael, Hidajat Heriawaty, Widjajahakim Grace, Utomo Ahmad Rusdan Hando |
ECCR1 and NFKB2 Polymorphisms as Potential Biomarkers of Non-small Cell Lung Cancer in a Polish Population. Anticancer research 2019 Jun 39 (6): 3269-3272. Chaszczewska-Markowska Monika, Kosacka Monika, Chryplewicz Agnieszka, Dy?a Tomasz, Brzecka Anna, Bogunia-Kubik Katarzy |
Potential mechanism of primary resistance to icotinib in patients with advanced non-small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi-center study. Cancer science 2019 12 111 (2): 679-686. Lei Lei, Wang Wen-Xian, Zhu You-Cai, Li Jin-Luan, Fang Yong, Wang Hong, Zhuang Wu, Zhang Yin-Bin, Wang Li-Ping, Fang Mei-Yu, Xu Chun-Wei, Wang Xiao-Jia, Lv Tang-Feng, Song Yo |
Successful treatment of a lung adenocarcinoma patient with a novel EGFR exon 20-ins mutation with afatinib: A case report. Medicine 2019 1 98 (1): e13890. Cai Yangyang, Wang Xu, Guo Ye, Sun Chao, Xu Yinghui, Qiu Shi, Ma Kew |
PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy. Lung cancer (Amsterdam, Netherlands) 2020 Feb 142 98-105. Chen Kaiyan, Cheng Guoping, Zhang Fanrong, Zhu Guanxia, Xu Yanjun, Yu Xiaoqing, Huang Zhiyu, Fan Y |
Osimertinib for Chinese advanced non-small cell lung cancer patients harboring diverse EGFR exon 20 insertion mutations. Lung cancer (Amsterdam, Netherlands) 2020 Dec 152 39-48. Yang Guang-Jian, Li Jun, Xu Hai-Yan, Sun Yang, Liu Liu, Li Hong-Shuai, Yang Lu, Zhang Yuan, Li Guo-Hui, Wang Y |
APOBEC3B deletion polymorphism and lung cancer risk in the southern Chinese population. Annals of translational medicine 2021 Apr 9 (8): 656. Ben Xiaosong, Tian Dan, Liang Jiayu, Wu Min, Xie Fan, Zheng Jinlong, Chen Jingmin, Fei Qiaoyuan, Guo Xinrong, Weng Xueqiong, Liu Shan, Xie Xin, Ying Yuting, Qiao Guibin, Jing Chunx |
Polymorphism in Thymidylate Synthase Gene Predicts Survival and Toxicity in North Indian Lung Cancer Patients Undergoing Platinum-Based Doublet Chemotherapy. Oncology 2022 1 . Sharma Parul, Singh Navneet, Sharma Siddhar |
Association between Polymorphism of Genes IL-1A, NFKB1, PAR1, TP53, and UCP2 and Susceptibility to Non-Small Cell Lung Cancer in the Brazilian Amazon. Genes 2023 2 14 (2): . Pereira Esdras E B, Modesto Antônio A C, Fernandes Bruno M, Burbano Rommel M R, Assumpção Paulo P, Fernandes Marianne R, Guerreiro João F, Santos Sidney E B Dos, Santos Ney P C D |
Identification of h-TERT Promoter Mutations in Germline DNA from North Indian Lung Carcinoma Patients. Indian journal of clinical biochemistry : IJCB 2023 1 38 (1): 120-127. Prasad Rajendra, Panchal Sonia, Rani Isha, Kishan Jai, Parashar Gaur |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: